- Home
- AIRE vs IMMX Comparison
AIRE vs IMMX Comparison
Compare AIRE & IMMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIRE
- IMMX
- Stock Information
- Founded
- AIRE 2021
- IMMX 2014
- Country
- AIRE United States
- IMMX United States
- Employees
- AIRE N/A
- IMMX N/A
- Industry
- AIRE
- IMMX Medicinal Chemicals and Botanical Products
- Sector
- AIRE
- IMMX Health Care
- Exchange
- AIRE Nasdaq
- IMMX Nasdaq
- Market Cap
- AIRE 17.4M
- IMMX 61.1M
- IPO Year
- AIRE N/A
- IMMX 2021
- Fundamental
- Price
- AIRE $0.33
- IMMX $2.09
- Analyst Decision
- AIRE Strong Buy
- IMMX Strong Buy
- Analyst Count
- AIRE 1
- IMMX 1
- Target Price
- AIRE $1.25
- IMMX $7.00
- AVG Volume (30 Days)
- AIRE 397.2K
- IMMX 261.4K
- Earning Date
- AIRE 08-21-2025
- IMMX 08-11-2025
- Dividend Yield
- AIRE N/A
- IMMX N/A
- EPS Growth
- AIRE N/A
- IMMX N/A
- EPS
- AIRE N/A
- IMMX N/A
- Revenue
- AIRE $1,853,629.00
- IMMX N/A
- Revenue This Year
- AIRE $369.52
- IMMX N/A
- Revenue Next Year
- AIRE $68.67
- IMMX N/A
- P/E Ratio
- AIRE N/A
- IMMX N/A
- Revenue Growth
- AIRE 1925.60
- IMMX N/A
- 52 Week Low
- AIRE $0.30
- IMMX $1.26
- 52 Week High
- AIRE $4.49
- IMMX $3.00
- Technical
- Relative Strength Index (RSI)
- AIRE 27.49
- IMMX 52.67
- Support Level
- AIRE $0.31
- IMMX $2.16
- Resistance Level
- AIRE $0.49
- IMMX $2.46
- Average True Range (ATR)
- AIRE 0.04
- IMMX 0.17
- MACD
- AIRE -0.00
- IMMX -0.02
- Stochastic Oscillator
- AIRE 11.13
- IMMX 27.33
About AIRE reAlpha Tech Corp.
ReAlpha Tech Corp is a real estate technology company. The group is engaged in an end-to-end commission-free homebuying platform. It develops and utilizes its artificial intelligence-focused technology stack to empower retail investor participation in short-term rental properties, which are real estate units listed for a rental term. It provides short-term rental investment opportunities to everyday investors. The company has developed technologies and tools that allow for the analysis of short-term rental properties using AI to provide insight into that property's potential profitability and ways to increase such profitability. The company's reportable segments are; Platform Services and the Rental business segment.
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.